A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic ...
Scientists engineer E. coli to convert PET plastic bottle waste into L-DOPA, a primary treatment for Parkinson’s disease.
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Researchers said the breakthrough could lead to a ‘bio-upcycling industry’ that uses waste materials to make things like ...
Scientists have discovered how to turn used plastic bottles into a drug to treat Parkinson’s disease. Researchers at the University of Edinburgh genetically engineered bacteria to break down waste ...
After that first conversation Scott said to his new care adviser, "You are a lifeline." Parkinson's is a neurodegenerative ...
GlobalData on MSN
Parkinson’s research reaches “pivotal” stage, but barriers remain
Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.
Scientists have developed a method for turning plastic bottles into a medicine for the treatment of Parkinson's disease. The study showed that with the help of specially modified E. coli bacteria, ...
Oprah Daily on MSN
There is an effective surgical treatment for Parkinson’s. Why aren’t more women with the disease getting it?
Deep brain stimulation, or DBS, is like a pacemaker for the brain—and can hugely improve symptoms. Here is everything you need to know.
Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...
A treatment developed at Children's Mercy is moving to trials for use in patients with dystopia and Parkinson's disease.
ABP News on MSN
ABP Live Doc Talk: Rethinking Parkinson’s Treatment Through Patient Experience And Recovery Outcomes
To the clinical eye, Parkinson’s Disease is defined by the degradation of dopamine-producing neurons in the substantia nigra.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results